Hello, my name is Jennifer O'Sullivan, and I'm a clinical hematologist and a DPhil student working in the MRC Weatherall Institute of Molecular Medicine. I work with Professor Adam Mead, whose group focuses on the development of blood cancers, particularly myeloid neoplasms. So the MRC Weatherall Institute of Molecular Medicine studies a broad range of diseases but focusing on hematology, immunology, oncology, and neuroscience. And I think collectively, the major goal for across all of the areas is to discover newer therapies and advance our understanding of the diseases that each individual group are studying. So my project is studying a particular group of blood cancers called myeloproliferative neoplasms. These are a group of cancers that a genetic change is acquired within the very rare blood bone marrow stem cells. And I'm particularly focusing on why some of these blood cancers progress to a more advanced stage where we have limited therapies. So ultimately, I'm trying to find changes within these stem cells that we can target and develop new therapies. For my project, I am particularly focusing on the rare bone marrow stem cells. And very nicely, the Sony MA900 allows me to detect these stem cells and isolate them precisely into the plates that I position them in to process later downstream. And it is a machine that I can operate independently from the beginning of the process to completion. So to isolate these rare stem cells, I really require a machine that allows me to precisely position the cells in the well in a time-efficient manner, and the MA900 allows me to do this. It is able to sort the cells very precisely into the well. And it additionally allows me to do this very efficiently and is very user-friendly, in terms of being able to change the position of the plate, and adjust it very straightforwardly and quite quickly. The MA900 has a number of benefits, but I think particularly importantly, is extremely user-friendly. So for my project, it allows me to, from beginning to completion, independently process my sample without requiring the assistance of one of the facility managers, but I think this can be even more broadly applied to all users, from people who do bulk sourcing into tubes, to people who use plates with either 96 wells or someone like myself who uses 384 wells. And it has very nice features where you can be guided through troubleshooting so that you can solve any issues, that maybe arise, yourself for the most part. And this can be done quite efficiently and precisely. So the future of my work I see, particularly for this technology, moving from a research arena, potentially into more of a clinical utility, which is very exciting. And also particularly, hopefully, finding new targets for these group of patients where treatments are currently quite limited.